Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,750,000
+$574,000 QoQ
Shares Held
1,000,000
-21.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#18
of 210 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOVO HOLDINGS A/S holds $1,241,938,796 across 18 Biotechnology names. ELVN ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $217,370,500 | |
| 2 | COAG |
Hemab Therapeutics Holdings, Inc.
|
4,180,550 | $153,551,601 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $132,128,532 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,125,000 | $131,703,750 | |
| 5 | AVLN |
Avalyn Pharma Inc.
|
3,883,289 | $127,837,873 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,500,000 | $52,110,000 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
This page
|
1,000,000 | $50,750,000 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,320,000 | $49,394,400 |
All Filings in ELVN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,750,000 | 1,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,176,000 | 1,280,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,792,000 | 1,480,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,195,542 | 1,426,260 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,753,705 | 1,084,432 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||